These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26977311)

  • 1. Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS).
    Messer L; Alsaleh G; Georgel P; Carapito R; Waterham HR; Dali-Youcef N; Bahram S; Sibilia J
    RMD Open; 2016; 2(1):e000196. PubMed ID: 26977311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands.
    Houten SM; van Woerden CS; Wijburg FA; Wanders RJ; Waterham HR
    Eur J Hum Genet; 2003 Feb; 11(2):196-200. PubMed ID: 12634869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.
    Cuisset L; Drenth JP; Simon A; Vincent MF; van der Velde Visser S; van der Meer JW; Grateau G; Delpech M;
    Eur J Hum Genet; 2001 Apr; 9(4):260-6. PubMed ID: 11313769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
    Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
    Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D.
    Frenkel J; Houten SM; Waterham HR; Wanders RJ; Rijkers GT; Duran M; Kuijpers TW; van Luijk W; Poll-The BT; Kuis W
    Rheumatology (Oxford); 2001 May; 40(5):579-84. PubMed ID: 11371670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous V377I mutation causing mevalonate kinase.
    Brito T; Banganho D; Pedrosa C; Farela Neves J
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35387795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.
    D'Osualdo A; Picco P; Caroli F; Gattorno M; Giacchino R; Fortini P; Corona F; Tommasini A; Salvi G; Specchia F; Obici L; Meini A; Ricci A; Seri M; Ravazzolo R; Martini A; Ceccherini I
    Eur J Hum Genet; 2005 Mar; 13(3):314-20. PubMed ID: 15536479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease.
    Thors VS; Vastert SJ; Wulffraat N; van Royen A; Frenkel J; de Sain-van der Velden M; de Koning TJ
    Pediatrics; 2014 Feb; 133(2):e461-5. PubMed ID: 24470648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
    Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
    Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.
    Stoffels M; Jongekrijg J; Remijn T; Kok N; van der Meer JW; Simon A
    Rheumatology (Oxford); 2015 Feb; 54(2):363-8. PubMed ID: 25173351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.
    Ammouri W; Cuisset L; Rouaghe S; Rolland MO; Delpech M; Grateau G; Ravet N
    Rheumatology (Oxford); 2007 Oct; 46(10):1597-600. PubMed ID: 17804452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.
    Houten SM; Kuis W; Duran M; de Koning TJ; van Royen-Kerkhof A; Romeijn GJ; Frenkel J; Dorland L; de Barse MM; Huijbers WA; Rijkers GT; Waterham HR; Wanders RJ; Poll-The BT
    Nat Genet; 1999 Jun; 22(2):175-7. PubMed ID: 10369261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
    Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
    J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
    Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
    Front Immunol; 2019; 10():1900. PubMed ID: 31474985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mevalonate kinase deficiency].
    Galeotti C
    Rev Prat; 2023 Oct; 73(8):850-854. PubMed ID: 38354005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.
    Santos JA; Aróstegui JI; Brito MJ; Neves C; Conde M
    Gene; 2014 Jun; 542(2):217-20. PubMed ID: 24656624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
    Takada K; Aksentijevich I; Mahadevan V; Dean JA; Kelley RI; Kastner DL
    Arthritis Rheum; 2003 Sep; 48(9):2645-51. PubMed ID: 13130485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.
    Drenth JP; Cuisset L; Grateau G; Vasseur C; van de Velde-Visser SD; de Jong JG; Beckmann JS; van der Meer JW; Delpech M
    Nat Genet; 1999 Jun; 22(2):178-81. PubMed ID: 10369262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
    Houten SM; Koster J; Romeijn GJ; Frenkel J; Di Rocco M; Caruso U; Landrieu P; Kelley RI; Kuis W; Poll-The BT; Gibson KM; Wanders RJ; Waterham HR
    Eur J Hum Genet; 2001 Apr; 9(4):253-9. PubMed ID: 11313768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.